Myriad Genetics (MYGN) Return on Capital Employed Growth (1y) (2012 - 2026)
Myriad Genetics (MYGN) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -17.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 42.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 732.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 44.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -18.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 42.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -1,014.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -251.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 21.00 |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -5,507.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,507.00 |
| Dec 31, 2025 | -5,249.00 |
| Sep 30, 2025 | -6,334.00 |
| Jun 30, 2025 | -4,858.00 |
| Mar 31, 2025 | 935.00 |
| Dec 31, 2024 | 1,209.00 |
| Sep 30, 2024 | 1,655.00 |
| Jun 30, 2024 | 1,106.00 |
| Mar 31, 2024 | -766.00 |
| Dec 31, 2023 | -1,279.00 |
| Sep 30, 2023 | -1,686.00 |
| Jun 30, 2023 | -1,254.00 |
| Mar 31, 2023 | -97.00 |
| Dec 31, 2022 | 379.00 |
| Sep 30, 2022 | 839.00 |
| Jun 30, 2022 | 2,188.00 |
| Mar 31, 2022 | 3,195.00 |
| Dec 31, 2021 | 3,478.00 |
| Sep 30, 2021 | 2,486.00 |
| Jun 30, 2021 | -825.00 |